APA (7th ed.) Citation

O, K., M, B., Z, S., RW, R., M, Z., R, C., . . . J, W. (2023). Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiency. Neuro-oncology advances, 5(1), vdad102. https://doi.org/10.1093/noajnl/vdad102

Chicago Style (17th ed.) Citation

O, Kim, et al. "Combined Inhibition of Topoisomerase I and Poly(ADP-ribose) Polymerase: A Synergistic Therapeutic Strategy for Glioblastoma with Phosphatase and Tensin Homolog Deficiency." Neuro-oncology Advances 5, no. 1 (2023): vdad102. https://doi.org/10.1093/noajnl/vdad102.

MLA (9th ed.) Citation

O, Kim, et al. "Combined Inhibition of Topoisomerase I and Poly(ADP-ribose) Polymerase: A Synergistic Therapeutic Strategy for Glioblastoma with Phosphatase and Tensin Homolog Deficiency." Neuro-oncology Advances, vol. 5, no. 1, 2023, p. vdad102, https://doi.org/10.1093/noajnl/vdad102.